EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Optimization of the Dose-Volume Effect Parameter “a” in EUD-Based TCP Models for Breast Cancer Radiotherapy

Farshid Mahmoudi iD, Nahid Chegeni iD, Ali Bagheri iD, Amir Danyaei iD, Samira Razzaghi iD, Shole Arvandi iD, Amal Saki Malehi iD, Bahare Arjmand iD, Azin Shamsi iD, Majid Mohiuddin iD

Technology in Cancer Research & Treatment · 2025-06 · 24

DOI: 10.1177/15330338251329103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 31.03.2025. Verfasst von Farshid Mahmoudi und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Allied Medical Sciences, Lorestan University of Medical Sciences, Khorramabad, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Radiotherapy Planning, Computer-Assisted. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ahvaz Jundishapur University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Radiotherapy treatment plans traditionally rely on physical indices like Dose-volume histograms and spatial dose distributions. While these metrics assess dose delivery, they lack consideration for the biological effects on tumors and healthy tissues. To address this, radiobiological models like tumor control probability (TCP) and Normal tissue complications probability (NTCP) are increasingly incorporated to evaluate treatment efficacy and potential complications. This study aimed to assess the predictive power of radiobiological models for TCP in breast cancer radiotherapy and provide insights into the model selection and parameter optimization.

Methods

In this retrospective observational study, two commonly used models, the Linear-Poisson and Equivalent uniform dose (EUD)-based models, were employed to calculate TCP for 30 patients. Different radiobiological parameter sets were investigated, including established sets from literature (G 1 and G 2 ) and set with an optimized “a” parameter derived from clinical trial data (a 1 and a 2 ). Model predictions were compared with clinical outcomes from the START trials.

Results

The Linear-Poisson model with es lished parameter sets from the literature demonstrated good agreement with clinical data. The standard EUD-based model (a = -7.2) significantly underestimated TCP. While both models exhibited some level of independence from the specific parameter sets (G 1 vs. G 2 ), the EUD-based model was susceptible to the “a” parameter value. Optimization suggests a more accurate “a” value closer to -2.57 and -5.65.

Conclusion

This study emphasizes the importance of clinically relevant radiobiological parameters for accurate TCP prediction and optimizing the “a” parameter in the EUD-based model based on clinical data (a1 and a2) improved its predictive accuracy significantly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsRadiotherapy Planning, Computer-AssistedHumansFemaleRadiotherapy DosageRetrospective StudiesDose-Response Relationship, RadiationTreatment Outcome

Stichwörter der Autor:innen

Breast Cancer RadiotherapyEUD-based ModelLinear-Poisson ModelRadiobiological ParametersTumor Control Probability (TCP)dose-volume effect

Autor:innen und Institutionen

  • School of Allied Medical Sciences, Lorestan University of Medical Sciences, Khorramabad, Iran.
  • Department of Medical Physics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Department of Radiation Oncology, Faculty of Medicine, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Pain Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Department of Biostatistics and Epidemiology, Faculty of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Department of Radiation Oncology, Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

ORCID-Profile: Farshid Mahmoudi, Nahid Chegeni, Ali Bagheri, Amir Danyaei, Samira Razzaghi, Shole Arvandi, Amal Saki Malehi, Bahare Arjmand, Azin Shamsi, Majid Mohiuddin

Förderung

  • Ahvaz Jundishapur University of Medical Sciences

Zitieren

APA

Mahmoudi, F., Chegeni, N., Bagheri, A., Danyaei, A., Razzaghi, S., Arvandi, S., Saki Malehi, A., Arjmand, B., Shamsi, A., & Mohiuddin, M. (2025). Optimization of the Dose-Volume Effect Parameter “a” in EUD-Based TCP Models for Breast Cancer Radiotherapy. Technology in Cancer Research & Treatment, 24. https://doi.org/10.1177/15330338251329103

Vancouver

Mahmoudi F, Chegeni N, Bagheri A, Danyaei A, Razzaghi S, Arvandi S, et al. Optimization of the Dose-Volume Effect Parameter “a” in EUD-Based TCP Models for Breast Cancer Radiotherapy. Technology in Cancer Research & Treatment. 2025;24. doi:10.1177/15330338251329103

BibTeX
@article{Mahmoudi2025,
  author = {Mahmoudi, Farshid and Chegeni, Nahid and Bagheri, Ali and Danyaei, Amir and Razzaghi, Samira and Arvandi, Shole and Saki Malehi, Amal and Arjmand, Bahare and Shamsi, Azin and Mohiuddin, Majid},
  title = {Optimization of the Dose-Volume Effect Parameter “a” in EUD-Based TCP Models for Breast Cancer Radiotherapy},
  journal = {Technology in Cancer Research & Treatment},
  year = {2025},
  volume = {24},
  doi = {10.1177/15330338251329103}
}
Kostenlos starten →